Summary
Pathological studies suggest that cisplatin injures different portions of the nephron to different extents. To investigate this issue further, we examined the cytotoxicity and uptake of cisplatin in cell lines derived from S1 and S3 proximal tubule and distal convoluted tubule segments isolated from a mouse carrying the SV40 large T-antigen transgene. S1 cells displayed the highest sensitivity to cisplatin cytotoxicity, followed by S3 and distal convuluted tubule (DCT) cells. These differences in cytotoxicity did not correlate with differences in cisplatin uptake. Cytotoxic concentrations of cisplatin triggered apoptosis in all three cell lines. Although BAX and BCL-2 expression was similar among the three cell lines, the expression of the anti-apoptotic protein, BCL-XL, was significantly lower in S1 cells than in S3 and DCT cells, and this may have contributed to the heightened sensitivity of S1 cells. Cisplatin transport characteristics demonstrated a saturable component of cisplatin uptake and differences in apparent K M and V max values among the three cell lines. The three cell lines were 43- to 176-fold more sensitive to cisplatin than to carboplatin. This distinction between the two drugs could not be fully explained by differences in the uptake rates of carboplatin and cisplatin. We conclude that cells from different portions of the nephron display different sensitivities to cisplatin, different transport characteristics for cisplatin and different levels of expression of BCL-XL. In addition, the relative resistance of renal cells to carboplatin vs cisplatin is mostly due to the differential effects that follow internalization.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Binks, S. P. & Dobrota, M. (1990). Kinetics and mechanics of uptake of platinum-based pharmaceuticals by the rat small intestine. Biochem Pharmacol 40: 1329–1336.
Blachley, J. D. & Hill, J. B. (1981). Renal and electrolyte disturbances associated with cisplatin. Ann Int Med 95: 628–632.
Brady, H. R., Kone, B. C., Stromski, M. E., Zeidel, M. L., Giebisch, G. & Gullans, S. R. (1990). Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules. Am J Physiol 258: F1181–F1187.
Chopra, S., Kaufman, J. S., Jones, T. W., Hong, W. K., Gehr, M. K., Hamburger, R. J. & Trump, B. F. (1982). Cis-diamminedichloroplatinum-induced acute renal failure in the rat. Kidney Int 21: 54–64.
Colvin, M. (1993). Alkylating agents and platinum antitumor compounds. In Cancer Medicine, Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR (eds), pp. 733–754, Lea & Febiger: Philadelphia
Daley-Yates, P. T. & McBrien, D. C. (1984). Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin. Biochem Pharmacol 33: 3063–3070.
Dive, C. & Hickman, J. A. (1991). Drug–target interactions: only the first step in the commitment to a programmed cell death?. Br J Cancer 64: 192–196.
Fady, C., Gardner, A., Jacoby, F., Briskin, K., Tu, Y., Schmid, I. & Lichtenstein, A. K. (1995). Atypical apoptotic cell death induced in L929 targets by exposure to tumor necrosis factor. J Interferon Cytokine Res 15: 71–80.
Gonzalez-Vitale, J. C., Hayes, D. M., Cvitkovic, E. & Sternberg, S. S. (1977). The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer 39: 1362–1371.
Guo, J. H. (1992). Relationship between plasma and urinary platinum pharmacokinetics with cisplatin nephrotoxicity in breast cancer patients. Chung-Hua Chung Liu Tsa Chih Chinese J Oncol 14: 150–153.
Hospers, G. A. P., Mulder, N. H., de Jong, B., de Ley, L., Uges, D. R. A., Fichtinger-Schepman, A. M. J., Scheper, R. J. & de Vries, E. G. E. (1988). Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro. Cancer Res 48: 6803–6807.
Kaunitz, J. D., Cummins, V. P., Mishler, D. & Nagami, G. T. (1993). Inhibition of gentamicin uptake into cultured mouse proximal tubule epithelial cells by L-lysine. J Clin Pharmacol 33: 63–69.
Klaushofer, K., Varga, F., Glantschnig, H., Fratzl-Zelman, N., Czerwenka, E., Leis, H. J., Koller, K. & Peterlik, M. (1995). The regulatory role of thyroid hormones in bone cell growth and differentiation. J Nutrition 125(suppl. 7): 1996S–2003S.
Knox, R. J., Freidlos, F., Lydall, D. A. & Roberts, J. J. (1986). Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum (II) and cis-diammine (1,1-cyclobutanedicarboxylate) platinum (II) differ only in the kinetics of their interaction with DNA. Cancer Res 46: 1972–1979.
Leibbrandt, M. E. I., Wolfgang, G. H. I., Metz, A. L., Ozobia, A. A. & Haskins, J. R. (1995). Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells. Kidney Int 48: 761–770.
Lieberthal, W., Triaca, V. & Levine, J. (1996). Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol 270: F700–F708.
Loehrer, P. J. & Einhorn, L. H. (1984). Cisplatin. Ann Int Med 100: 704–713.
Mann, S. C., Andrews, P. A. & Howell, S. B. (1990). Short-term cis-diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Chemother Pharmacol 35: 236–240.
Mellish, K. J., Kelland, L. R. & Harrap, K. R. (1993). In Vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Br J Cancer 68: 240–250.
Micetich, K. C., Barnes, D. & Erickson, L. L. (1985). A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino) (1,1-cyclobutanedicarboxylate)-platinum (II) and cis-diamminedichloroplatinum (II) on L1210 cells. Cancer Res 45: 4043–4047.
Minn, A. J., Rudin, C. M., Boise, L. & Thompson, C. B. (1995). Expression of BCL-X-L can confer a multidrug resistance phenotype. Blood 86: 1903–1910.
Mistry, P., Lee, C. & McBrien, D. C. (1989). Intracellular metabolites of cisplatin in the rat kidney. Cancer Chemother Pharmacol 24: 73–79.
Miyashita, T. & Reed, J. C. (1992). BCL-2 gene transfer increases relative resistance of S49.1 and WEHI 7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and chemotherapeutic drugs. Cancer Res 52: 5407–5411.
Nagami, G. T., Warech, E. M. & Mischler, D. R. (1990). ells derived from S1, S2 and S3 proximal tubule segments of a transgenic mouse. J Am Soc Nephrol 1: 656
Nagami, G. T., Warech, E. M. & Mischler, D. R. (1991). Effect of angiotensin II on ammonia production by mouse S1 and S3 proximal tubule cell lines. J Am Soc Nephrol 2: 707–707.
Nagami, G. T., Warech, E. M. & Mischler, D. R. (1992). Ammonia production and transport by cultured proximal tubule cells grown on permeable supports. J Am Soc Nephrol 3: 783–783.
Palmiter, R. D., Chen, H. Y., Messing, A. & Brinster, R. L. (1985). SV 40 enhancer and large-T antigen are instrumental in development of choroid plexus tumors in transgenic mice. Nature 316: 457–460.
Parti, R. & Wolf, W. (1990). Quantitative subcellular distribution of platinum in rat tissues following i.v. bolus and i.v. infusion of cisplatin. Cancer Chemother Pharmacol 26: 188–192.
Schurig, J. E., Rose, W. C., Catino, J. J., Gaver, R. C., Long, B. H., Madissoo, H. & Canetta, R. (1990). The Pharmacologic Characteristics of Carboplatin: Preclinical Experience. In Carboplatin (JM-8), Current Perspectives and Future Directions, Bunn PA, Canetta R, Ozols RF, Rosencweig M (eds), pp. 3–17, WB Saunders: Philadelphia
Simonian, P. C., Grillot, D. A. M. & Nunez, G. (1997). BCL-2 and BCL-XL can differentially block chemotherapy induced cell death. Blood 90: 1208–1216.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Kröning, R., Katz, D., Lichtenstein, A. et al. Differential effects of cisplatin in proximal and distal renal tubule epithelial cell lines. Br J Cancer 79, 293–299 (1999). https://doi.org/10.1038/sj.bjc.6690047
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690047
Keywords
This article is cited by
-
Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells
Cellular and Molecular Life Sciences (2019)
-
Establishment of renal proximal tubule cell lines derived from the kidney of p53 knockout mice
Cytotechnology (2019)
-
Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation
Apoptosis (2008)